Found: 83
Select item for more details and to access through your institution.
Changes in thumb tapping rates and central motor conduction times are associated in persons with multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
State and trait of finger tapping performance in multiple sclerosis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96485-3
- By:
- Publication type:
- Article
Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
- Published in:
- Journal of NeuroVirology, 2008, v. 14, n. 2, p. 143, doi. 10.1080/13550280801958922
- By:
- Publication type:
- Article
Haematological Effects of Interferon-β-1a (Rebif®) Therapy in Multiple Sclerosis.
- Published in:
- Drug Safety, 2004, v. 27, n. 10, p. 745, doi. 10.2165/00002018-200427100-00005
- By:
- Publication type:
- Article
Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Neue immungenetische Aspekte der multiplen Sklerose.
- Published in:
- Neuroforum, 2001, v. 7, n. 4, p. 121, doi. 10.1515/nf-2001-0403
- By:
- Publication type:
- Article
Building up the blood-brain barrier.
- Published in:
- Nature Medicine, 2003, v. 9, n. 7, p. 828, doi. 10.1038/nm0703-828
- By:
- Publication type:
- Article
CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation.
- Published in:
- Nature Medicine, 2002, v. 8, n. 6, p. 620, doi. 10.1038/nm0602-620
- By:
- Publication type:
- Article
Lymphokine Production by B Cells from Normal and HIV-Infected Individuals.
- Published in:
- Annals of the New York Academy of Sciences, 1992, v. 651, n. 1, p. 220, doi. 10.1111/j.1749-6632.1992.tb24617.x
- By:
- Publication type:
- Article
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211061550
- By:
- Publication type:
- Article
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 4, p. 1, doi. 10.1177/20552173211061550
- By:
- Publication type:
- Article
Inpatient Rehabilitation: Prediction of Changes in Sensorimotor Performance in Multiple Sclerosis: A Pilot Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 10, p. 2177, doi. 10.3390/jcm10102177
- By:
- Publication type:
- Article
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
- Published in:
- Multiple Sclerosis (13524585), 2004, v. 10, n. 2, p. 165, doi. 10.1191/1352458504ms991oa
- By:
- Publication type:
- Article
Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: Implications for multiple sclerosis.
- Published in:
- Journal of NeuroVirology, 2006, v. 12, n. 1, p. 65, doi. 10.1080/13550280600614973
- By:
- Publication type:
- Article
Human endogenous retrovirus (HERV)-W ENV and GAG proteins: Physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.
- Published in:
- Journal of NeuroVirology, 2005, v. 11, n. 1, p. 23, doi. 10.1080/13550280590901741
- By:
- Publication type:
- Article
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211058298
- By:
- Publication type:
- Article
Imatinib buys time for brain after stroke.
- Published in:
- Nature Medicine, 2008, v. 14, n. 7, p. 712, doi. 10.1038/nm0708-712
- By:
- Publication type:
- Article
Common Cellular and Diverse Genetic Basis of Thymoma-associated Myasthenia Gravis.
- Published in:
- Annals of the New York Academy of Sciences, 2008, v. 1132, p. 143, doi. 10.1196/annals.1405.018
- By:
- Publication type:
- Article
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 6, p. 819, doi. 10.1177/1352458518771875
- By:
- Publication type:
- Article
Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 12, p. 1594, doi. 10.1177/1352458517727603
- By:
- Publication type:
- Article
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 6, p. 818, doi. 10.1177/1352458516664033
- By:
- Publication type:
- Article
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1074, doi. 10.1177/1352458512469695
- By:
- Publication type:
- Article
Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 9, p. 1239, doi. 10.1177/1352458512436595
- By:
- Publication type:
- Article
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009).
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 4, p. 442, doi. 10.1177/1352458511422097
- By:
- Publication type:
- Article
Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013568
- By:
- Publication type:
- Article
mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis.
- Published in:
- PLoS ONE, 2008, v. 3, n. 2, p. 1, doi. 10.1371/journal.pone.0001530
- By:
- Publication type:
- Article
Excitability decreasing central motor plasticity is retained in multiple sclerosis patients.
- Published in:
- BMC Neurology, 2012, v. 12, n. 1, p. 92, doi. 10.1186/1471-2377-12-92
- By:
- Publication type:
- Article
Symptomatology of MS: results from the German MS Registry.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Socio-economic aspects of neuroimmunological diseases.
- Published in:
- Journal of Neurology, 2006, v. 253, p. v87, doi. 10.1007/s00415-006-5015-x
- By:
- Publication type:
- Article
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of Interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis.
- Published in:
- Journal of Neurology, 2005, v. 252, n. 5, p. 526, doi. 10.1007/s00415-005-0681-7
- By:
- Publication type:
- Article
Soluble Telencephalin in the serum of Children after Febrile Seizures.
- Published in:
- Journal of Neurology, 2005, v. 252, n. 4, p. 493, doi. 10.1007/s00415-005-0668-4
- By:
- Publication type:
- Article
Improving MS patient care.
- Published in:
- Journal of Neurology, 2004, v. 251, p. v69, doi. 10.1007/s00415-004-1511-z
- By:
- Publication type:
- Article
Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS): A two year follow-up study.
- Published in:
- Journal of Neurology, 2004, v. 251, n. 1, p. 30, doi. 10.1007/s00415-004-0265-y
- By:
- Publication type:
- Article
sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis - a cross-sectional pilot study.
- Published in:
- Journal of Neurology, 2002, v. 249, n. 8, p. 1001, doi. 10.1007/s00415-002-0772-7
- By:
- Publication type:
- Article
Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis.
- Published in:
- Journal of Molecular Medicine, 2005, v. 83, n. 10, p. 806, doi. 10.1007/s00109-005-0661-5
- By:
- Publication type:
- Article
Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Targeting Progressive Neuroaxonal Injury Lessons from Multiple Sclerosis.
- Published in:
- CNS Drugs, 2011, v. 25, n. 9, p. 783, doi. 10.2165/11587820-000000000-00000
- By:
- Publication type:
- Article
Genetic polymorphism of the tumor necrosis factor (TNF)-α promoter region in families with localized early-onset periodontitis.
- Published in:
- Journal of Periodontal Research, 2001, v. 36, n. 3, p. 183, doi. 10.1034/j.1600-0765.2001.360307.x
- By:
- Publication type:
- Article
EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units.
- Published in:
- European Journal of Human Genetics, 2011, v. 19, n. 4, p. 465, doi. 10.1038/ejhg.2010.196
- By:
- Publication type:
- Article
Going beyond PA: Assessing sensorimotor capacity with wearables in multiple sclerosis—a cross-sectional study.
- Published in:
- Journal of NeuroEngineering & Rehabilitation (JNER), 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12984-023-01247-z
- By:
- Publication type:
- Article
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2016, v. 73, n. 9, p. 1089, doi. 10.1001/jamaneurol.2016.1451
- By:
- Publication type:
- Article
Early Intervention in Multiple Sclerosis: Better Outcomes for Patients and Society?
- Published in:
- Drugs, 2003, v. 63, n. 15, p. 1525, doi. 10.2165/00003495-200363150-00001
- By:
- Publication type:
- Article
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
- Published in:
- Brain: A Journal of Neurology, 2011, v. 134, n. 3, p. 693, doi. 10.1093/brain/awr010
- By:
- Publication type:
- Article
Identification of macrophage populations expressing tumor necrosis factor-α mRNA in acute multiple sclerosis.
- Published in:
- Acta Neuropathologica, 1998, v. 95, n. 4, p. 373, doi. 10.1007/s004010050813
- By:
- Publication type:
- Article
Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 1, p. 15, doi. 10.2165/11593310-000000000-00000
- By:
- Publication type:
- Article
Microglial/macrophage expression of interleukin 10 in human glioblastomas.
- Published in:
- International Journal of Cancer, 1999, v. 82, n. 1, p. 12, doi. 10.1002/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O
- By:
- Publication type:
- Article
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.
- Published in:
- Annals of Neurology, 2013, v. 73, n. 6, p. 705, doi. 10.1002/ana.23938
- By:
- Publication type:
- Article
A PD‐1 polymorphism is associated with disease progression in multiple sclerosis.
- Published in:
- Annals of Neurology, 2005, v. 58, n. 1, p. 50
- By:
- Publication type:
- Article
Selective loss of regulatory T cells in thymomas.
- Published in:
- Annals of Neurology, 2004, v. 56, n. 6, p. 901
- By:
- Publication type:
- Article